What’s New

Patient Advocates Line Up Behind Federal Step Therapy Bill

A congressional effort to improve patients’ access to treatment is generating widespread enthusiasm in the advocacy community.  Sponsored by Rep. Brad Wenstrup, DPM, (R-Ohio) and

Read More

Cystic Fibrosis Group Defines Barriers to Treatment Access

Orphan drugs aren’t always reaching the patients who need them, and an advocacy group known as the Cystic Fibrosis Engagement Network has a few ideas

Read More

Drug Approval Signals New Era in Cancer Care

Is precision medicine gaining traction in the field of oncology?  The Food and Drug Administration’s recent approval of the cancer drug pembrolizumab offers a hint. 

Read More

High Out-of-Pocket Costs Threaten Access for Medicare Patients

Some Medicare beneficiaries pay 20 percent of their income in out-of-pocket medical expenses, a new study finds.  And a disproportionate number of those are low-income

Read More

The New Face of Hepatitis C

Long considered an affliction of the baby boomer generation, hepatitis C now has spiked among a surprising new population: young people. Hepatitis C infections hit

Read More

Drug Safety Data Underscores Need for Pharmacovigilance

One in every three new drugs triggers side effects discovered only after Food and Drug Administration approval, new data reveals.  And that statistic begs a

Read More

Access Issues Loom Large at Munich Workshop on Biologics and Biosimilars

By Brian Kennedy, Executive Director of the Global Alliance for Patient Access When should patients switch from one medicine to another for non-medical reasons?  How can

Read More

***PRESS RELEASE*** STATEMENT FROM ALLIANCE FOR PATIENT ACCESS ON SENATOR SANDERS’ DRUG IMPORTATION AMENDMENT

Physician organization urges lawmakers to prioritize access to safe, approved medications. WASHINGTON – The Alliance for Patient Access (AfPA) made the following statement about the amendment

Read More

How Balanced Treatment, Innovation & Better Policy Can Help Solve the Opioid Epidemic

“Doctor, make my pain go away.” I hear this plea, in one form or another, from patients on a daily basis.  Yet it presents physicians like

Read More

Clinical Trials Awareness Week Focuses on Policy, Participation

What can the federal government do to raise clinical trials awareness?  Maybe a lot, suggests one organization. May 1-5 marks Clinical Trials Awareness Week, when

Read More
Back to Top